Combination Therapy May Be Best for Intermediate Heart Disease Risks

Research shows that adding a cholesterol-lowering drug may have a significant effect on individuals who have high blood pressure but are not yet considered high-risk patients.

0
We dont tend to think of statins as antihypertensive medications, because they are designed to lower LDL cholesterol, not blood pressure. But recent research suggests that for many patients with high blood pressure, adding statins to their anti-hypertensive medication regimen may make a huge difference. In the Heart Outcomes Prevention Evaluation-3 (HOPE-3) trial, researchers explored various combinations of anti-hypertensive and cholesterol-lowering drugs among individuals considered to be at intermediate risk of coronary heart disease (CHD).
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access